Clinical Trials Browser

Phase 1 × OTHER × ipatasertib × Clear all

NCT04253561 2026-03-16

IPATHER

Phase 1 Completed

Breast Neoplasms

NCT03959891 2025-09-29

AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC)

Phase 1 Active not recruiting

Breast Neoplasms